Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine with CBT for PTSD
NCT00452231Phase 3Unknown
- Sponsor
- Université de Montréal
- Start
- Feb 2007
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of d-cycloserine in post-traumatic stress disorder (PTSD), sponsored by Université de Montréal. Status: unknown.
02
Drugs
d-cycloserine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00452231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00452231.